Kelley Shannon T
General Counsel
Kelley Shannon T has filed 3 SEC Form 4 filings (5 transaction rows) across 1 company, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Aug 20, 2026.
On the most recent filing, Kelley Shannon T is listed as General Counsel at MADRIGAL PHARMACEUTICALS, INC. Inside the rolling window, Kelley Shannon T reported no open-market purchases and 3 open-market sales totaling $842K in MDGL. The largest disclosed transaction in the window is a sale of 692 MDGL shares on Jan 20, 2026, worth $344K.
Companies traded
Other insiders at MDGL
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$842K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Kelley Shannon T made?
Kelley Shannon T has filed 3 SEC Form 4 filings (5 transaction rows) across 1 company since 2026.
Which companies does Kelley Shannon T trade?
Kelley Shannon T has filed SEC Form 4 disclosures for 1 company, including MDGL.
When was Kelley Shannon T's most recent SEC Form 4 filing?
Kelley Shannon T's most recent SEC Form 4 filing on Tracefour is dated Aug 20, 2026.
What is Kelley Shannon T's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Kelley Shannon T is listed as General Counsel.
What is Kelley Shannon T's total buy and sell value in the current window?
Inside the rolling retention window, Kelley Shannon T bought $0 and sold $842K based on SEC Form 4 filings.
What was Kelley Shannon T's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 692 MDGL shares on 2026-01-20, worth $344K, per SEC Form 4 filings.